Ann: FDA Extends New Drug Application Review Period for Illuccix, page-38

It will be interesting to see. The last estimated timeline had the TGA expectancy for around the 12/11/2021.

TGA did take the lead to grant priority evaluation so it will be interesting to see if they extend their decision timeline in line with FDA or provide the decision to grant within the estimated time frame on the basis of a priority evaluation.

Either way, it's easy to see the difficulty in hitting timelines in the face of COVID bombardment that the authorities are dealing with at the moment.

Tough environment for sure and I think that's what's holding the share price back as their is quite bit of risk until they get marketing authorization. But IMO if successful then it should see a quick 2x from its current price in the short term.

The issue I see is that if marketing authorization is spread out between countries over too long of a period - then it de-risks the company enough to open it up for a takeover without realizing the full potential.

So in my opinion, I would love for the FDA to announce their decision first as their market is the biggest. Followed by everyone else

This looked to be the plan by management but has been delayed slightly due to factors outside of their control.

I just hope that if someone does try to do a takeover then the offer is not for less than 6 billion.